Jialin Sun
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
ADAR1 regulates radiosensitivity in ESCC through cIAP2-NF-κB signaling and C16orf46 editing.
Journal: iScience
Published: March 27, 2026
Advancing Epigenetic Combination Therapy in Oncology: Multifunctional Nano-Drug Delivery Systems for Synergistic Efficacy and Precision Modulation.
Journal: International journal of nanomedicine
Published: September 08, 2025
Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 06, 2025
Published population pharmacokinetic models of mycophenolate sodium: a systematic review and external evaluation in a Chinese sample of renal transplant recipients.
Journal: Frontiers in pharmacology
Published: May 21, 2025
Nano-formulations in disease therapy: designs, advances, challenges, and future directions.
Journal: Journal of nanobiotechnology
Published: March 03, 2025
Analysis of risk factors in breast cancer patients with hand-foot syndrome and oral mucositis caused by pegylated liposomal doxorubicin.
Journal: Frontiers in oncology
Published: January 22, 2025
Selective Oxidation of Alcohol to Valuable Aldehydes Using Water as a Promoter in a Photoelectrochemical Cell.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: June 10, 2024
SLAMseq reveals potential transfer of RNA from liver to kidney in the mouse.
Journal: Nature communications
Published: May 16, 2024
Development of a Venous Thromboembolism Prophylaxis and Pain Medication Pathway in Thoracic Surgery Enhanced Recovery After Surgery Program.
Journal: The Journal of surgical research
Published: May 03, 2024
Comparison of General vs. Intraspinal Anesthesia in Lower Limb Fracture Surgery: A Prospective Study.
Journal: Alternative therapies in health and medicine
Published: April 06, 2024
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.
Journal: ImmunoTargets and therapy
Published: February 08, 2024
Last Updated: 09/26/2026